NetworkNewsBreaks Archive - Page 1932 of 1952

ThursdayNov 17, 2016 1:38 pm

NetworkNewsBreaks – Immune Pharmaceuticals (IMNP): $11 Million in New Financing Supports Bertilimumab Clinical Development

Immune Pharmaceuticals (NASDAQ: IMNP) is trading higher on news that it has secured up to $11 million in new financing from an existing single family office investor. The company continues to accumulate patients in two phase 2 clinical trials for its lead candidate bertilimumab for moderate-to-severe ulcerative colitis as well as for bullous pemphigoid, an orphan autoimmune dermatological condition. The company reports that in both conditions, a significant number of patients have elevated levels of eotaxin-1, considered a biomarker of disease severity. Targeting patients with elevated eotaxin-1 offers the potential to select patients who may be more likely to respond…

ThursdayNov 17, 2016 11:54 am

NetworkNewsBreaks – Plug Power, Inc. (PLUG) Signs Deal for Fuel Cell Electric Vehicle Development in China

Plug Power (NASDAQ: PLUG) is trading higher after announcing its cooperative memorandum of understanding (MOU) with Zhangjiagang Furui Special Equipment Co., LTD (Furui), along with one of the “big three” Chinese industrial vehicle manufacturers. Per the agreement, the three companies will collaborate to build electric vehicles equipped with Plug Power-designed hydrogen fueling station solutions and hybrid fuel cell engine systems. The program is expected to deliver two industrial delivery truck prototypes by March of 2017, both powered by Plug Power’s ProGen fuel cell engines. The deal also calls for a short-term project for more than 500 vehicles and a fueling…

ThursdayNov 17, 2016 11:52 am

NetworkNewsBreaks – AcelRx Pharmaceuticals, Inc. (ACRX) to Present ARX-04 SAP303 Study Results at Annual ASRA Pain Medicine Meeting

AcelRx Pharmaceuticals (NASDAQ: ACRX), focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, this morning announced its upcoming presentation of the complete results from the phase 3 SAP303 study of ARX-04. The presentation will take place at the ongoing 15th Annual Pain Medicine Meeting of the American Society of Regional Anesthesia and Pain Medicine (ASRA). To view the full press release, visit: http://nnw.fm/3cX1B About AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company's…

ThursdayNov 17, 2016 9:00 am

NetworkNewsBreaks – Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) Disposable Vaporizers Highlighted on Leafly.com

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) was featured in an article on Leafly titled ‘Product Review: The Wildflower Disposable Vape Pen’ authored by Darren Harris. The article features Wildflower's hybrid strain THC disposable vape pen, Eclipse. Consumers benefit from the discreetness of the pen while enjoying a powerful and smooth draw each time. The Eclipse pen is disposable and requires no charging, appealing to first time users and those who need a light and pleasant boost throughout the day. The article also features Wildflower's non-THC disposable pens, Aches and Immunity, which include not only CBD, but a unique blend of…

WednesdayNov 16, 2016 2:02 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on November 16, 2016

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: SGGV 44.44% – News: Acquires established global online gaming company, Euroclub Holding Limited PLFX 33.76% – News: Shareholder and investor conference call scheduled for November 22 HISP 46.20% – News: Issues shareholder update, offers corporate presentation NDEV 25.58% – News: Posts Q3 results, revenues increased 35% TPNL 20.00% – News: Turns to profit in Q3; revenues increase 38% to $2.8M AXIM 16.22% – News: Granted new U.S. patent allowance for use of all cannabinoids…

WednesdayNov 16, 2016 12:54 pm

The Female Health Company (FHCO) Names New Marketing VP for Veru Healthcare

The Female Health Company (NASDAQ: FHCO) today announced the appointment of Shiao Zhu as vice president of marketing for Veru Healthcare and the manager of the Pharmaceuticals & Medical Devices and Consumer Health divisions of The Female Health Company. Shiao Zhu has a background in both marketing and sales, including new products, branded generics, drugs for uterine fibroids, hormone replacement therapy, IUDs, infertility, human papilloma virus, and 505(b)(2) products. “In the role of Vice President of Marketing, Shiao will leverage her considerable expertise in product commercial development and positioning in men’s and women’s health and oncology to lead the marketing…

WednesdayNov 16, 2016 12:51 pm

MagneGas Corp. (MNGA) Announces $3M Placement; Shares Lower

Shares of MagneGas (NASDAQ: MNGA) are down more than 16% in mid-morning trade after the waste conversion company announced its agreement with a single institutional investor for a registered direct placement of approximately $3 million. The Securities Purchase Agreement provides for the sale of $2.5 million of pre-funded warrants which are exercisable into 5,102,041 shares and $500,000 in payment for 1,020,408 shares. The placement is expected to close on or before November 18, 2016, subject to satisfaction of customary closing conditions. To view the full press release, visit: http://nnw.fm/4lMKN About MagneGas Corporation MagneGas® Corporation (MNGA) owns a patented process that converts…

WednesdayNov 16, 2016 12:49 pm

Amyris, Inc. (AMRS) Collaboration Reaches “Key Milestone” in Oncology Drug Development

Amyris (NASDAQ: AMRS) shares are ticking higher after the industrial bioscience company said its collaboration with “one of the world’s leading” pharmaceutical companies has resulted in the creation of a “robust, sensitive activity assay for an oncology target in a live yeast strain.” This high-throughput assay enables screening for chemical diversity found in nature using Amyris’s proprietary µPharm™ platform, with the potential to provide previously inaccessible molecule targets. The µPharm platform combines two powerful technologies that Amyris said can significantly accelerate and reduce the cost of new drug discovery. To view the full press release, visit: http://nnw.fm/9LkVH About Amyris Amyris…

WednesdayNov 16, 2016 12:46 pm

Cemtrex, Inc. (CETX) Ranked as No. 213 Fastest Growing Company in North America

Cemtrex (NASDAQ: CETX) is trading 4% higher in morning trade after announcing that it has ranked No. 213 on Deloitte’s Technology Fast 500™. The industrial and manufacturing solutions company obtained its ranking based on revenue growth of 368% from 2012 to 2015. “We are proud of receiving this award now three times in the last 5 years and of our growth of over 350% during that time frame. Our goal is to continue to be a ‘Fast 500’ company for many years to come and we are confident that we can continue to grow at rapid pace,” Cemtrex’s chairman and…

TuesdayNov 15, 2016 3:26 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on November 15, 2016

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: LOGX 54.64% – News: Inks deal with established financial services firm NPHC 40.00% – News: Initiated infomercial test campaign for OTC drug for pain in animals UVND 32.81% – News: Posts over 50% revenue increase in Q3 NMUS 30.95% – News: Will present NB1111 data at 2016 AAPS national meeting CLRB 30.11% – News: Selects INC Research (NASDAQ: INCR) to oversee phase 2 clinical trial of CLR 131 BLIN 32.02% – News: iAPPS platform…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks